New smart drug takes aim at Hard-to-Treat cancers

NCT ID NCT06752681

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new drug called DAY301 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to deliver a powerful toxin directly to cancer cells while sparing healthy ones. The study aims to find the safest dose and check if the drug can shrink tumors. About 254 adults with specific cancers like ovarian, lung, or breast cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical squamous cell carcinoma endometrial cancer esophageal squamous cell carcinoma gastric adenocarcinoma gastroesophageal junction adenocarcinoma head and neck squamous cell carcinoma metastatic malignant neoplasm non-small cell lung carcinoma ovarian cancer small cell lung carcinoma triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Site: 001-039

    RECRUITING

    New York, New York, 10021, United States

  • Site: 001-057

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Site: 001-058

    RECRUITING

    New Haven, Connecticut, 06510, United States

  • Site: 001-059

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

  • Site: 001-060

    RECRUITING

    Indianapolis, Indiana, 46202, United States

  • Site: 001-063

    RECRUITING

    Lake Mary, Florida, 32746, United States

  • Site: 001-064

    RECRUITING

    Sarasota, Florida, 34232, United States

  • Site: 001-065

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Site: 001-069

    RECRUITING

    Houston, Texas, 77030, United States

  • Site: 001-073

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

  • Site: 011-005

    RECRUITING

    Toronto, Ontario, M5G 2M9, Canada

  • Site: 011-013

    RECRUITING

    Vancouver, British Columbia, V5Z 4E6, Canada